Literature DB >> 9396000

Survival in primary soft tissue sarcoma of the extremities and trunk.

M Peiper1, D Zurakowski, C Zornig.   

Abstract

BACKGROUND: Soft tissue sarcomas (STS) of the extremities are rare. The purpose of this study was to identify prognostic risk factors associated with survival in patients with primary extremity and truncal STS.
METHODS: Patient, tumor, and pathologic data from 149 consecutive patients with localized primary STS of the extremities and trunk were analyzed using Kaplan-Meier and Cox regression techniques to identify univariate and multivariate risk factors. A subgroup analysis was performed to compare factors predictive of survival in patients who received treatment before (n = 50) and after (n = 99) treatment was standardized in 1988.
RESULTS: The 5-year survival rate was 76.5% with an average follow-up of 6 years. Local recurrence occurred in 23% of all patients, 40% before 1988 and 15% after 1988 (P < 0.0001). Risk factors associated with survival included resection quality (R0 vs. R1; P < 0.0001), era of operation (P = 0.002), local recurrence (P < 0.001), UICC stage (P < 0.0001), tumor size (P < 0.001), tumor depth (P = 0.002), regional lymph nodes (P < 0.0001), and histology (P < 0.0001). Multivariate analysis revealed that tumor size, tumor depth, and resection quality were independent risk factors of survival.
CONCLUSIONS: These results indicate that management of STS in a specialized institution improves overall survival. Resection quality is the most important risk factor of survival. Therefore, effort should be made during primary treatment of STS to achieve wide, tumor-free resection margins.

Entities:  

Mesh:

Year:  1997        PMID: 9396000     DOI: 10.1007/bf02391867

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  3 in total

1.  Analysis of Clinical Outcomes of Patients with Soft Tissue Sarcoma.

Authors:  Lokesh Garg; Manish Pruthi; Ullas Batra; D C Doval; Sunil Pasricha; Jiten Jaipuria; Jagandeep Singh Virk; Akshay Tiwari
Journal:  Indian J Surg Oncol       Date:  2022-02-10

Review 2.  [Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Authors:  Hildegard Pape; Klaus Orth; Rainer Engers; Christiane Matuschek; Anja Müller; Karl-Axel Hartmann; Peter Arne Gerber; Guido Lammering; Daniel Habermehl; Roland Fenk; Wilfried Budach; Stephan Gripp; Matthias Peiper; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.

Authors:  Christiane Matuschek; Marcus Lehnhardt; Peter Arne Gerber; Christopher Poremba; Jackson Hamilton; Guido Lammering; Klaus Orth; Wilfried Budach; Hans Bojar; Edwin Bölke; Matthias Peiper
Journal:  Eur J Med Res       Date:  2014-02-03       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.